Investing tools
DCF calculator for Indian stocks
Pick a company, see the growth its price already assumes, then change the assumptions and watch the fair value move.
Showing Automotive Stampings and Assemblies. See Automotive Stampings and Assemblies company page →
What the price assumes
AttractiveTo justify its price of ₹453, this stock must grow earnings at 13% every year for 7 years. Our analysis caps realistic growth at ~49%. At that growth it is worth ₹2649 — upside of 485%.
- Growth the price implies
- 12.9% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 50.3% a year
- net profit, FY23–FY26 · EPS 49.2%
- The gap
- -0.4 pp
- 485% downside if it only repeats history
Your assumptions
Change any of these and the value moves. A valuation that flips on a one-point change in the required return is telling you something.
Value on these assumptions
₹2,706.5
Against today's price
+497%
7 projected years, then a terminal value at 4.0%.
Normalized net profit is discounted as a proxy for owner earnings, not full free cash flow. An analytical tool, not investment advice.
How to read this valuation
- Start from the price, not the forecast. A normal DCF asks you to guess growth and hands back a fair value. Run backwards, it takes today's price and solves for the earnings growth the market is already assuming.
- Compare that with what the company has done. The historical profit and EPS CAGR sit beside the implied number. A price that needs 25% a year from a business that has compounded at 10% is asking a lot, and the gap is the risk you are taking on.
- Then apply your own view. Change the growth rate, how long it lasts, how it fades and the return you require. A valuation that flips on a one-point change in the discount rate is telling you something about itself.
- Mind the caveats. Normalized net profit stands in for owner earnings, not full free cash flow; terminal growth is capped at 6%, roughly nominal GDP; cyclicals are flagged because a peak-earnings base overstates value. This is an analytical tool, not investment advice.